Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic

E-ISSN： 1873-5576|17|6|505-511

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.6, 2017-06, pp. : 505-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection

Current Medicinal Chemistry, Vol. 25, Iss. 7, 2018-03 ,pp. : 802-813

Bentham Science Publishers

Access to resources Recommend Favorite

Lamivudine is effective in paediatric patients with chronic hepatitis B virus (HBV) infection

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Occult hepatitis C and B virus infections in hepatocellular carcinoma

By Carreño Vicente

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 31-33

Future Medicine

Access to resources Recommend Favorite

Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma

Current Drug Targets, Vol. 3, Iss. 5, 2002-10 ,pp. : 369-378

Bentham Science Publishers

Access to resources Recommend Favorite